This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window
American Economic Journal: Applied Economics: Vol. 4 No. 3 (July 2012)
AEJ: Applied Volume. 4, Issue 3 | 
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
AEJ: Applied Forthcoming Articles
Full-text Article
Download Data Set (72.87 MB) | Online Appendix (181.05 KB)
View Comments on This Article (0) | Login to post a comment
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter Subscription Information
(Institutional Administrator Access)
Explore:
AEJ: Applied Forthcoming Articles
Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-cholesterol Drugs
Article Citation
Dunn, Abe. 2012. "Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-cholesterol Drugs."
American Economic Journal: Applied Economics,
4(3): 167-89.
DOI: 10.1257/app.4.3.167
DOI: 10.1257/app.4.3.167
Abstract
The pharmaceutical industry is characterized as having substantial
investment in R&D and a large number of new product introductions, which poses special problems for price measurement caused by the quality of drug products changing over time. This paper applies recent demand estimation techniques to individual-level data to construct a constant-quality price index for anti-cholesterol drugs. Although the average price for anti-cholesterol drugs does not change over the sample period, I find that the constant-quality price index drops by 27 percent, a pace more in line with our expectations in such a dynamic segment of the industry. (JEL C43, L11, L65, O31)
Article Full-Text Access
Full-text Article
Additional Materials
Download Data Set (72.87 MB) | Online Appendix (181.05 KB)
Authors
Dunn, Abe (US Bureau of Economic Analysis)
JEL Classifications
C43: Index Numbers and Aggregation; Leading indicators
L11: Production, Pricing, and Market Structure; Size Distribution of Firms
L65: Chemicals; Rubber; Drugs; Biotechnology
O31: Innovation and Invention: Processes and Incentives
L11: Production, Pricing, and Market Structure; Size Distribution of Firms
L65: Chemicals; Rubber; Drugs; Biotechnology
O31: Innovation and Invention: Processes and Incentives
Comments
View Comments on This Article (0) | Login to post a comment
